Foothills Asset Management Ltd. acquired a new stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the second quarter, Holdings Channel reports. The institutional investor acquired 26,135 shares of the pharmacy operator’s stock, valued at approximately $2,047,000.

A number of other institutional investors have also made changes to their positions in WBA. RB Capital Management LLC acquired a new position in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $261,000. Russell Investments Group Ltd. increased its position in shares of Walgreens Boots Alliance by 72.9% in the first quarter. Russell Investments Group Ltd. now owns 482,962 shares of the pharmacy operator’s stock valued at $40,115,000 after buying an additional 203,635 shares during the period. PagnatoKarp Partners LLC acquired a new position in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $236,000. Barings LLC increased its position in shares of Walgreens Boots Alliance by 219.1% in the fourth quarter. Barings LLC now owns 28,602 shares of the pharmacy operator’s stock valued at $2,367,000 after buying an additional 19,639 shares during the period. Finally, Sumitomo Mitsui Asset Management Company LTD increased its position in shares of Walgreens Boots Alliance by 9.3% in the first quarter. Sumitomo Mitsui Asset Management Company LTD now owns 75,821 shares of the pharmacy operator’s stock valued at $6,296,000 after buying an additional 6,462 shares during the period. 61.21% of the stock is currently owned by institutional investors.

Shares of Walgreens Boots Alliance, Inc. (WBA) opened at 79.80 on Friday. Walgreens Boots Alliance, Inc. has a 52 week low of $75.18 and a 52 week high of $88.00. The company’s 50 day moving average price is $79.35 and its 200-day moving average price is $82.62. The stock has a market capitalization of $85.39 billion, a PE ratio of 20.15 and a beta of 1.26.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.30 by $0.03. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. The firm had revenue of $30.12 billion during the quarter, compared to analysts’ expectations of $29.72 billion. During the same period in the previous year, the firm posted $1.18 EPS. Walgreens Boots Alliance’s revenue for the quarter was up 2.1% on a year-over-year basis. Equities research analysts predict that Walgreens Boots Alliance, Inc. will post $5.01 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 12th. Shareholders of record on Friday, August 18th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 2.01%. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. The ex-dividend date of this dividend is Wednesday, August 16th. Walgreens Boots Alliance’s payout ratio is 37.78%.

Walgreens Boots Alliance announced that its Board of Directors has initiated a share buyback program on Wednesday, April 5th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the pharmacy operator to purchase shares of its stock through open market purchases. Shares buyback programs are often a sign that the company’s board of directors believes its shares are undervalued.

ILLEGAL ACTIVITY WARNING: This news story was reported by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this news story can be accessed at https://www.dailypolitical.com/2017/07/21/26135-shares-in-walgreens-boots-alliance-inc-nasdaqwba-acquired-by-foothills-asset-management-ltd.html.

WBA has been the topic of several research analyst reports. Zacks Investment Research downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Wednesday, June 14th. Leerink Swann set a $90.00 price objective on Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Tuesday, April 11th. Jefferies Group LLC cut their price objective on Walgreens Boots Alliance from $95.00 to $80.00 and set a “buy” rating on the stock in a research report on Wednesday, May 31st. Needham & Company LLC initiated coverage on Walgreens Boots Alliance in a research report on Tuesday, June 27th. They issued a “hold” rating on the stock. Finally, Robert W. Baird reaffirmed an “outperform” rating and issued a $96.00 price objective on shares of Walgreens Boots Alliance in a research report on Monday, March 27th. Three investment analysts have rated the stock with a sell rating, three have issued a hold rating and fourteen have given a buy rating to the stock. Walgreens Boots Alliance currently has an average rating of “Buy” and an average target price of $90.69.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction dated Wednesday, May 3rd. The stock was sold at an average price of $85.89, for a total transaction of $234,995.04. Following the completion of the sale, the director now directly owns 21,887 shares of the company’s stock, valued at approximately $1,879,874.43. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 13.50% of the stock is owned by insiders.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.